4- [2 - [[5-methyl-1- (2-naphthalenyl) -1h-pyrazol-3-yl] oxy] ethyl] morpholine salt, process for the preparation of the hydrochloride salt, pharmaceutical composition and hydrochloride salt
LLUIS SOLÀ-CARANDELL,María Rosa Cuberes-Altisent,Urko García-Couceiro
申请号：
BR112012012456
公开号：
BR112012012456A2
申请日:
2010.11.25
申请国别(地区):
BR
年份:
2020
代理人:
摘要：
4- [2 - [[5-methyl-1- (2-naphthalenyl) -1h-pyrazol-3-yl] oxy] ethyl] morpholine salt, process for the preparation of the hydrochloride salt, pharmaceutical composition and hydrochloride salt . the present invention relates to the salts of 4 - [- 2 [[5-methyl-1- (2-naphthalenyl) -1h-pyrazol-3-yl] ox] ethyl] morpholine, specifically hydrochloride, to pharmaceutical compositions comprising the same, and their use in therapy and / or prophylaxis of diseases associated with the sigma receptor.sal de 4-[2-[[5-metil-1-(2-naftalenil)-1h-pirazol-3-il]oxi]etil]morfolina,processo para a preparação do sal de cloridrato, composição farmacêutica e sal de cloridrato. a presente invenção refere-se aos sais de 4-[-2[[5-metil-1-(2-naftalenil)-1h-pirazol-3-il]ox]etil]morfolina, especificamente ao cloridrato, á composições farmacêuticas compreendendo os mesmos, e ao seus usos na terapia e/ou profilaxia de doenças associadas ao receptor sigma.
